Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Cecilia Furlong Analyst Performance

Analyst at Morgan Stanley

Cecilia Furlong is a stock analyst at Morgan Stanley in the medical sector, covering 8 publicly traded companies. Over the past year, Cecilia Furlong has issued 8 stock ratings, including buy and hold recommendations. While full access to Cecilia Furlong's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Cecilia Furlong's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
22 Last 4 Years
Buy Recommendations
50.00% 11 Buy Ratings
Companies Covered
8 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%11 ratings
Hold50.0%11 ratings
Sell0.0%0 ratings

Out of 22 total stock ratings issued by Cecilia Furlong at Morgan Stanley, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
75.0% of companies on NYSE
6 companies
NASDAQ
25.0% of companies on NASDAQ
2 companies

Cecilia Furlong, an analyst at Morgan Stanley, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
100.0%

Cecilia Furlong of Morgan Stanley specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
5 companies
62.5%
MED INSTRUMENTS
2 companies
25.0%
MEDICAL INFO SYS
1 company
12.5%

Cecilia Furlong's Ratings History at Morgan Stanley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
1/12/2026Reiterated Rating$163.80Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
12/2/2025Boost Price Target$182.25$205.00Overweight
Medtronic PLC stock logo
MDT
Medtronic
11/19/2025Boost Price Target$100.69$117.00Overweight
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
11/10/2025Boost Price Target$6.56$6.00Equal Weight
Medtronic PLC stock logo
MDT
Medtronic
7/15/2025Reiterated Rating$89.05$107.00Overweight
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
7/15/2025Boost Price Target$3.58$4.00Equal Weight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
7/15/2025Lower Price Target$138.91$147.00Overweight
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
6/11/2025Boost Price Target$148.82$160.00Overweight
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
5/6/2025Lower Price Target$91.25$95.00Equal Weight